Articles de revues sur le sujet « IT-ret »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « IT-ret ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Drilon, Alexander E., Dayong Zhai, Evan Rogers, et al. "The next-generation RET inhibitor TPX-0046 is active in drug-resistant and naïve RET-driven cancer models." Journal of Clinical Oncology 38, no. 15_suppl (2020): 3616. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3616.
Texte intégralAmmer, Stefanie, Christian Lambertz, and Matthias Gauly. "Comparison of different measuring methods for body temperature in lactating cows under different climatic conditions." Journal of Dairy Research 83, no. 2 (2016): 165–72. http://dx.doi.org/10.1017/s0022029916000182.
Texte intégralHennige, Anita M., Reiner Lammers, Wolfgang Höppner, et al. "Inhibition of Ret Oncogene Activity by the Protein Tyrosine Phosphatase SHP1." Endocrinology 142, no. 10 (2001): 4441–47. http://dx.doi.org/10.1210/endo.142.10.8453.
Texte intégralDurick, Kyle, Gordon N. Gill, and Susan S. Taylor. "Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2." Molecular and Cellular Biology 18, no. 4 (1998): 2298–308. http://dx.doi.org/10.1128/mcb.18.4.2298.
Texte intégralCarlomagno, Francesca, Teresa Guida, Suresh Anaganti, et al. "Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474." Endocrine-Related Cancer 16, no. 1 (2009): 233–41. http://dx.doi.org/10.1677/erc-08-0213.
Texte intégralJones, Stanton L. "Rational-Emotive Therapy in Christian Perspective." Journal of Psychology and Theology 17, no. 2 (1989): 110–20. http://dx.doi.org/10.1177/009164718901700203.
Texte intégralWang, Lei, Yu Zhang, Yu Gao, et al. "Prognostic and Predictive Values of Subcellular Localisation of RET in Renal Clear-Cell Carcinoma." Disease Markers 2016 (2016): 1–8. http://dx.doi.org/10.1155/2016/6870470.
Texte intégralDawasaz, A. A., Ibrahim Alshahrani, Syed M. Yassin, et al. "Detection of Dental Caries’ and Dermatoglyphics’ Association with Relative Enamel Thickness Using CBCT Images in Saudi Subpopulation: A Novel Approach." BioMed Research International 2021 (July 26, 2021): 1–7. http://dx.doi.org/10.1155/2021/5550916.
Texte intégralZhang, Kai, Huajun Chen, Ye Wang, et al. "Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients." Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 27, no. 5 (2019): 575–82. http://dx.doi.org/10.3727/096504018x15344979253618.
Texte intégralCorsini, Raymond J. "Putting the “B” in ret: It had to be." Journal of Rational-Emotive and Cognitive-Behavior Therapy 13, no. 1 (1995): 5–7. http://dx.doi.org/10.1007/bf02354554.
Texte intégralAhn, Beung-chul, Viola W. Zhu, and Sun Min Lim. "The Next Target for NSCLC: Let It Be “RET”." Journal of Thoracic Oncology 15, no. 12 (2020): 1803–5. http://dx.doi.org/10.1016/j.jtho.2020.09.008.
Texte intégralSapio, Maria Rosaria, Anna Guerra, Vincenzo Marotta, et al. "High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements." Journal of Clinical Endocrinology & Metabolism 96, no. 6 (2011): E916—E919. http://dx.doi.org/10.1210/jc.2010-1599.
Texte intégralFusco, Alfredo, and Massimo Santoro. "20 years of RET/PTC in thyroid cancer: clinico-pathological correlations." Arquivos Brasileiros de Endocrinologia & Metabologia 51, no. 5 (2007): 731–35. http://dx.doi.org/10.1590/s0004-27302007000500010.
Texte intégralPelicci, Giuliana, Flavia Troglio, Alessandra Bodini, et al. "The Neuron-Specific Rai (ShcC) Adaptor Protein Inhibits Apoptosis by Coupling Ret to the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway." Molecular and Cellular Biology 22, no. 20 (2002): 7351–63. http://dx.doi.org/10.1128/mcb.22.20.7351-7363.2002.
Texte intégralSantoro, M., W. T. Wong, P. Aroca, et al. "An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway." Molecular and Cellular Biology 14, no. 1 (1994): 663–75. http://dx.doi.org/10.1128/mcb.14.1.663-675.1994.
Texte intégralSantoro, M., W. T. Wong, P. Aroca, et al. "An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway." Molecular and Cellular Biology 14, no. 1 (1994): 663–75. http://dx.doi.org/10.1128/mcb.14.1.663.
Texte intégralWu, Jie, and Vivek Subbiah. "RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion–Positive Breast Cancer and Beyond." Cancer Research 83, no. 19 (2023): 3159–61. http://dx.doi.org/10.1158/0008-5472.can-23-1021.
Texte intégralVargiolu, Manuela, Daniela Fusco, Ivana Kurelac, et al. "The Tyrosine Kinase Receptor RET Interacts in Vivo with Aryl Hydrocarbon Receptor-Interacting Protein to Alter Survivin Availability." Journal of Clinical Endocrinology & Metabolism 94, no. 7 (2009): 2571–78. http://dx.doi.org/10.1210/jc.2008-1980.
Texte intégralChatterjee, Sumantra, Lauren E. Fries, Or Yaacov, Nan Hu, Hanna E. Berk-Rauch, and Aravinda Chakravarti. "RET enhancer haplotype-dependent remodeling of the human fetal gut development program." PLOS Genetics 19, no. 11 (2023): e1011030. http://dx.doi.org/10.1371/journal.pgen.1011030.
Texte intégralAhmed, Attique, and Muhammad Naeem. "A Novel Framework for Selecting Elicitation Technique based on Attribute Mapping." International Journal of Engineering and Applied Computer Science 04, no. 02 (2022): 19–24. http://dx.doi.org/10.24032/ijeacs/0402/001.
Texte intégralLuesma, M. J., I. Cantarero, J. M. Álvarez-Dotu, S. Santander, and C. Junquera. "New Insights into c-Ret Signalling Pathway in the Enteric Nervous System and Its Relationship with ALS." BioMed Research International 2014 (2014): 1–7. http://dx.doi.org/10.1155/2014/328348.
Texte intégralRocco, Danilo, Luigi Sapio, Luigi Della Gravara, Silvio Naviglio, and Cesare Gridelli. "Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes." International Journal of Molecular Sciences 24, no. 3 (2023): 2433. http://dx.doi.org/10.3390/ijms24032433.
Texte intégralRungngu, Susanti Lisupindan Palimbong, Audrey Wahani, and Max F. J. Mantik. "Reticulocyte hemoglobin equivalent for diagnosing iron deficiency anemia in children." Paediatrica Indonesiana 56, no. 2 (2016): 90. http://dx.doi.org/10.14238/pi56.2.2016.90-4.
Texte intégralRobb, Harold B. "Using RET to Reduce Psychological Dysfunction Associated with Supernatural Belief Systems." Journal of Cognitive Psychotherapy 7, no. 4 (1993): 281–89. http://dx.doi.org/10.1891/0889-8391.7.4.281.
Texte intégralTang, Ming-Jer, Dane Worley, Michele Sanicola, and Gregory R. Dressler. "The RET–Glial Cell-derived Neurotrophic Factor (GDNF) Pathway Stimulates Migration and Chemoattraction of Epithelial Cells." Journal of Cell Biology 142, no. 5 (1998): 1337–45. http://dx.doi.org/10.1083/jcb.142.5.1337.
Texte intégralYusof, Nurasyikin. "The Paediatric Iron Deficiency Assessment with Reticulocyte Haemoglobin Equivalent (Ret-He) in Comparison with Biochemical Markers of Serum Ferritin and Transferrin Saturation." Medicine & Health 16, no. 2 (2021): 138–47. http://dx.doi.org/10.17576/mh.2021.1602.10.
Texte intégralSong, Xingju, Xu Yang, Taotao Zhang, Jing Liu, and Qun Liu. "A Novel Rhoptry Protein as Candidate Vaccine against Eimeria tenella Infection." Vaccines 8, no. 3 (2020): 452. http://dx.doi.org/10.3390/vaccines8030452.
Texte intégralAlqahtani, Tariq, Vishnu Kumarasamy, Sahar Saleh Alghamdi, et al. "Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes." Cancers 15, no. 7 (2023): 2163. http://dx.doi.org/10.3390/cancers15072163.
Texte intégralLivia, Resvi, Fajar Wasilah, and Leni Lismayanti. "Comparison of Reticulocyte Hemoglobin Equivalent Levels between Low and Normal Birth Weight Newborns." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 29, no. 1 (2023): 64–68. http://dx.doi.org/10.24293/ijcpml.v29i1.1943.
Texte intégralZhu, Yongqiang, Jia Wang, and Minghong Shang. "Abstract LB330: FHND5071: a selective RET inhibitor with unique pharmacokinetic profile." Cancer Research 83, no. 8_Supplement (2023): LB330. http://dx.doi.org/10.1158/1538-7445.am2023-lb330.
Texte intégralGou, Qitao, Xiaochuan Gan, Longhao Li, Qiheng Gou, and Tao Zhang. "Precious Gene: The Application of RET-Altered Inhibitors." Molecules 27, no. 24 (2022): 8839. http://dx.doi.org/10.3390/molecules27248839.
Texte intégralBunker, Lisa D., Christina Nessler, and Julie L. Wambaugh. "Effect Size Benchmarks for Response Elaboration Training: A Meta-Analysis." American Journal of Speech-Language Pathology 28, no. 1S (2019): 247–58. http://dx.doi.org/10.1044/2018_ajslp-17-0152.
Texte intégralKhatri, Ujjwol, Neetu Dayal, Xueqing Hu, et al. "Abstract 3851: Targeting RET solvent-front mutants with an alkynyl nicotinamide-based inhibitor." Cancer Research 83, no. 7_Supplement (2023): 3851. http://dx.doi.org/10.1158/1538-7445.am2023-3851.
Texte intégralSijmons, R. H., R. M. W. Hofstra, F. A. Wijburg, et al. "Oncological implications of RET gene mutations in Hirschsprung’s disease." Gut 43, no. 4 (1998): 542–47. http://dx.doi.org/10.1136/gut.43.4.542.
Texte intégralSahakian, Nicolas, Frédéric Castinetti, and Pauline Romanet. "Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET." Cancers 15, no. 19 (2023): 4865. http://dx.doi.org/10.3390/cancers15194865.
Texte intégralPeng, Hai Xin, and Rui Kang. "Stimulate and Eliminate Electronic Product Design Defects By Reliability Enhancement Testing." Advanced Materials Research 663 (February 2013): 621–25. http://dx.doi.org/10.4028/www.scientific.net/amr.663.621.
Texte intégralDi Cristofaro, J., V. Vasko, V. Savchenko, et al. "ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators: comparison with sporadic tumors from Ukrainian and French patients." Endocrine-Related Cancer 12, no. 1 (2005): 173–83. http://dx.doi.org/10.1677/erc.1.00884.
Texte intégralBhujbal, Swapnil P., Seketoulie Keretsu, and Seung Joo Cho. "Molecular Modelling Studies on Pyrazole Derivatives for the Design of Potent Rearranged during Transfection Kinase Inhibitors." Molecules 26, no. 3 (2021): 691. http://dx.doi.org/10.3390/molecules26030691.
Texte intégralSung, Bongsuk, and Woo-Yong Song. "Are Political Factors More Relevant Than Economic Factors in Firm-Level Renewable Energy Technology Export? Evidence from Path Analysis." Sustainability 13, no. 16 (2021): 8788. http://dx.doi.org/10.3390/su13168788.
Texte intégralLin, Hao, Yujie Liu, Ruitao Zhou, et al. "Noncanonical RET fusions in Chinese patients with non-small cell lung cancer from DNA-based next-generation sequencing." Journal of Clinical Oncology 42, no. 16_suppl (2024): e20000-e20000. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e20000.
Texte intégralImtiaz, Isma, Ayesha Younas, Ayisha Imran, Abuzar Siddique, Nauman Aslam Malik, and Akhtar Sohail Chughtai. "SIGNIFICANCE OF MEASURING RETICULOCYTE HEMOGLOBIN (RET-HE) IN CHRONIC KIDNEY DISEASE PATIENTS." Pakistan Journal of Pathology 34, no. 2 (2023): 37–41. http://dx.doi.org/10.55629/pakjpathol.v34i2.748.
Texte intégralKotani, Takaya, Junya Takegaki, Ryo Takagi, Koichi Nakazato, and Naokata Ishii. "Consecutive bouts of electrical stimulation-induced contractions alter ribosome biogenesis in rat skeletal muscle." Journal of Applied Physiology 126, no. 6 (2019): 1673–80. http://dx.doi.org/10.1152/japplphysiol.00665.2018.
Texte intégralStanescu, Laura-Semonia, Adina Ghemigian, Mihai-Lucian Ciobica, et al. "Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid RET Pathogenic Variants in Medullary Thyroid Cancer/Multiple Endocrine Neoplasia Type 2 (MEN2)." International Journal of Molecular Sciences 25, no. 18 (2024): 9765. http://dx.doi.org/10.3390/ijms25189765.
Texte intégralBorrello, Maria Grazia, Antonella Aiello, Bernard Peissel, et al. "Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism." Endocrine-Related Cancer 18, no. 4 (2011): 519–27. http://dx.doi.org/10.1530/erc-10-0306.
Texte intégralGarcia-Rendueles, Angela R., Miguel Chenlo, Fernando Oroz-Gonjar, et al. "RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas." Oncogene 40, no. 45 (2021): 6354–68. http://dx.doi.org/10.1038/s41388-021-02009-8.
Texte intégralLoura, Luís M. S., Rodrigo F. M. de Almeida, and Manuel Prieto. "Methodologies and formalisms of resonance energy transfer in biophysics. Application to membrane model systems." International Journal of Photoenergy 5, no. 4 (2003): 223–31. http://dx.doi.org/10.1155/s1110662x03000369.
Texte intégralMuhibullah, Nouman Shafique, Navneet Kaur, et al. "Efficacy and safety of selpercatinib in advanced RET-altered thyroid cancers: A meta-analysis and systematic review." Journal of Clinical Oncology 42, no. 16_suppl (2024): e18073-e18073. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e18073.
Texte intégralPrazeres, Hugo, Joana Torres, Fernando Rodrigues, et al. "How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer." Journal of Thyroid Research 2011 (2011): 1–10. http://dx.doi.org/10.4061/2011/678357.
Texte intégralCetta, Francesco, Gennaro Chiappetta, Rosa Marina Melillo, et al. "The ret/ptc1 Oncogene Is Activated in Familial Adenomatous Polyposis-Associated Thyroid Papillary Carcinomas1." Journal of Clinical Endocrinology & Metabolism 83, no. 3 (1998): 1003–6. http://dx.doi.org/10.1210/jcem.83.3.4614.
Texte intégralIbáñez, Carlos F., Gustavo Paratcha та Fernanda Ledda. "RET-independent signaling by GDNF ligands and GFRα receptors". Cell and Tissue Research 382, № 1 (2020): 71–82. http://dx.doi.org/10.1007/s00441-020-03261-2.
Texte intégral